Improvement and development direction of bariatric metabolic surgery / 中华消化外科杂志

In more than half a century of the development of bariatric metabolic surgery, a variety of classic surgical methods have been formulated. However, the improvement and innovation of bariatric metabolic surgery has never stopped. The replacement of new and old surgical methods in clinical application and development reflects the vitality and progress in the field of bariatric metabolic surgery, and also promotes the development of bariatric metabolic surgery to the best balance between benefits and risks. In the early stages, studies in metabolic surgery are more inclined to confirm the efficacy, safety and mechanism of classical procedures. In recent years, metabolic surgeons around the world have become more inclined to focus on the exploration and innovation of new procedures. In addition, the improvement of biliopancreatic diversion with duodenal switch and the sleeve gastrectomy plus procedures have gradually become hot spots for surgical innovation. However, the new techniques are diverse, scattered and partially overlapping. The authors make a comment on this content, in order to provide assistance to clinical and scientific research.

Application value of quantitative computed tomography for evaluation of changes in abdominal fat after laparoscopic Roux-en-Y gastric bypass in obese patients / 中华消化外科杂志

Objective@#To evaluate the application value of quantitative computed tomography for evaluation of changes in abdominal fat after laparoscopic Roux-en-Y gastric bypass in obese patients.@*Methods@#The retrospective and descriptive study was conducted. The clinical data of 52 obese patients who underwent laparoscopic Roux-en-Y gastric bypass in the Third Medical Center of Chinese PLA General Hospital from March 2011 to February 2012 were collected. There were 24 males and 28 females, aged (43±9)years, with the range of 23-62 years. All the 52 patients underwent laparoscopic Roux-en-Y gastric bypass. Observation indicators: (1) surgical and postoperative conditions; (2) changes in anthropometric indices; (3) follow-up. Follow-up using outpatient examination was performed to detect complications of patients at 1, 3, 6, 12 months after surgery up to February 2013. Measurement data with normal distribution were represented as Mean±SD, repeated measurement data were analyzed using repeated ANOVA. Count data were represented as absolute numbers.@*Results@#(1) Surgical and postoperative conditions: all the patients underwent laparoscopic Roux-en-Y gastric bypass successfully, without conversion to open surgery. The volume of intraoperative blood loss, operation time, and duration of hospital stay were (25±11)mL, (78±14)minutes, and (11±2)days. (2) Changes in anthropometric indices: the body mass index (BMI), fat mass, free fat mass, total abdominal fat volume (TAFV), total subcutaneous fat volume (TSFV), and total visceral fat volume (TVFV) of all the 52 patients were (31.8±1.8)kg/m2, (39.4±4.1)kg, (50.2±6.0)kg, (11 703±3 899)cm3, (7 418±2 969)cm3, and (4 314±1 692)cm3 before surgery, (28.5±1.4)kg/m2, (33.0±1.1)kg, (49.7±4.6)kg, (11 016±3 713)cm3, (7 044±2 970)cm3, (3 969±1 443)cm3 at 3 months after surgery, (27.1±1.7)kg/m2, (30.2±1.3)kg, (45.4±3.1)kg, (9 406±4 452)cm3, (6 442±3 307)cm3, and (2 964±1 694)cm3 at 6 months after surgery, (24.4±2.4)kg/m2, (32.6±1.1)kg, (48.6±2.7)kg, (7 612±3 029)cm3, (5 623±2 650)cm3, and (1 826±360)cm3 at 12 months after surgery, respectively, there were significant differences in the changes of these indices (F=130.2, 30.3, 4.9, 25.6, 11.9, 16.5, P<0.05). The BMI, fat mass, and TAFV at 3 months after surgery had significant differences compared with those before surgery (P<0.05), but free fat mass, TSFV, and TVFV had no significant difference (P>0.05). The BMI, fat mass, TAFV, and TVFV at 6 months after surgery had significant differences compared with those before surgery (P<0.05), but free fat mass and TSFV had no significant difference (P>0.05). The BMI, fat mass, TAFV, TSFV, and TVFV at 12 months after surgery had significant differences compared with those before surgery (P<0.05), but free fat mass had no significant difference (P>0.05). (3) Follow-up: all the 52 patients have completed the follow-up after surgery and the remission number of obesity was 35. No complications such as anastomotic hemorrhage, obstruction, or anastomotic leakage occured in all the 52 patients.@*Conclusion@#Laparoscopic Roux-en-Y gastric bypass can reduce abdominal visceral fat significantly, while quantitative computed tomography can help to evaluate the distribution of abdominal visceral fat accurately.

Application value of quantitative computed tomography for evaluation of changes in abdominal fat after laparoscopic Roux-en-Y gastric bypass in obese patients / 中华消化外科杂志

Objective To evaluate the application value of quantitative computed tomography for evaluation of changes in abdominal fat after laparoscopic Roux-en-Y gastric bypass in obese patients.Methods The retrospective and descriptive study was conducted.The clinical data of 52 obese patients who underwent laparoscopic Roux-en-Y gastric bypass in the Third Medical Center of Chinese PLA General Hospital from March 2011 to February 2012 were collected.There were 24 males and 28 females,aged (43±9)years,with the range of 23-62 years.All the 52 patients underwent laparoscopic Roux-en-Y gastric bypass.Observation indicators:(1) surgical and postoperative conditions;(2) changes in anthropometric indices;(3) follow-up.Follow-up using outpatient examination was performed to detect complications of patients at 1,3,6,12 months after surgery up to February 2013.Measurement data with normal distribution were represented as Mean±SD,repeated measurement data were analyzed using repeated ANOVA.Count data were represented as absolute numbers.Results (1) Surgical and postoperative conditions:all the patients underwent laparoscopic Roux-en-Y gastric bypass successfully,without conversion to open surgery.The volume of intraoperative blood loss,operation time,and duration of hospital stay were (25± 11) mL,(78± 14) minutes,and (11±2) days.(2) Changes in anthropometric indices:the body mass index (BMI),fat mass,free fat mass,total abdominal fat volume (TAFV),total subcutaneous fat volume (TSFV),and total visceral fat volume (TVFV) of all the 52 patients were (31.8 ± 1.8)kg/m2,(39.4±4.1)kg,(50.2±6.0)kg,(l1 703±3 899)cm3,(7 418±2 969)cm3,and (4 314± 1 692)cm3 before surgery,(28.5±1.4)kg/m2,(33.0±1.1)kg,(49.7±4.6)kg,(11 016±3 713) cm3,(7 044± 2970)cm3,(3969±1 443)cm3 at 3 months after surgery,(27.1±1.7)kg/m2,(30.2±1.3)kg,(45.4± 3.1)kg,(9 406±4 452)cm3,(6 442±3 307)cm3,and (2 964±1 694) cm3 at 6 months after surgery,(24.4± 2.4)kg/m2,(32.6±1.1)kg,(48.6±2.7)kg,(7 612±3 029)cm3,(5 623±2 650)cm3,and (1 826±360) cm3 at 12 months after surgery,respectively,there were significant differences in the changes of these indices (F=130.2,30.3,4.9,25.6,11.9,16.5,P＜0.05).The BMI,fat mass,and TAFV at 3 months after surgery had significant differences compared with those before surgery (P＜0.05),but free fat mass,TSFV,and TVFV had no significant difference (P＞0.05).The BMI,fat mass,TAFV,and TVFV at 6 months after surgery had significant differences compared with those before surgery (P ＜ 0.05),but free fat mass and TSFV had no significant difference (P＞0.05).The BMI,fat mass,TAFV,TSFV,and TVFV at 12 months after surgery had significant differences compared with those before surgery (P＜0.05),but free fat mass had no significant difference (P＞ 0.05).(3) Follow-up:all the 52 patients have completed the follow-up after surgery and the remission number of obesity was 35.No complications such as anastomotic hemorrhage,obstruction,or anastomotic leakage occured in all the 52 patients.Conclusion Laparoscopic Roux-en-Y gastric bypass can reduce abdominal visceral fat significantly,while quantitative computed tomography can help to evaluate the distribution of abdominal visceral fat accurately.

Effect of gastric bypass surgery on intestinal flora and some serum indexes in rats with type 2 diabetes mellitus / 中华内分泌外科杂志

Objective To observe the effect of gastric bypass (GBS) on intestinal flora and some serum indexes in spontaneous type 2 diabetic rats (GK rats),and to explore the mechanism of improving insulin resistance.Methods 30 Goto-Kakizaki rats,aged 8 weeks,were randomly divided into GBS operation group,sham operation group and diet matching group (n=10).Another 10 8-week-old male SD rats served as blank control group (free eating and drinking).The levels of fasting blood glucose(FPG) and fasting insulin(FINS) were measured and compared before and 4 weeks after operation.The insulin resistance index(HOMA-IR) was calculated before and 4 weeks after operation.Fresh feces of rats were collected 4 weeks after operation and DNA was extracted.The intestinal flora composition of each group was detected by real-time polymerase chain reaction (RT-PCR) at 4 weeks after operation.Results Four weeks after operation,FPG level in GBS group decreased from (13.83±0.35) mmol/L to (5.73±0.21) mmol/L(P＜0.05),HOMA-IR in GBS group decreased from(5.71±0.27) to (2.15±0.17) (P＜0.05).The DNA content of Firmicutes(22.71±12.81)(P=0.020),Enterobacterium spp.(3.11±4.17) (P=0.043) decreased significantly,and the DNA content of Bacteroides (30.74± 17.33) (P=0.013)increased significantly.Conclusion GBS can down-regulate the intestinal thick-walled bacterium,Enterobacteriaceae and upregulate the content of mimetic bacterium in type 2 diabetic rats,improve insulin resistance and insulin sensitivity.

Diabetes remission rate in different bmi grades following roux-en-y gastric bypass / Taxa de remissão do diabete em diferentes imcs após bypass gástrico em y-de-roux

ABSTRACT Background: Type 2 diabetes mellitus has a high long-term remission rate after laparoscopic Roux-en-Y gastric bypass (LRYGB), but few studies have analyzed patients with BMI<35 kg/m2. Aim: To compare glycemic control after LRYGB between BMI 30-35 kg/m2 (intervention group or IG) and >35 kg/m2 patients (control group or CG) and to evaluate weight loss, comorbidities and surgical morbidity. Methods: Sixty-six diabetic patients (30 in IG group and 36 in CG group) were submitted to LRYGB. Data collected annually after surgery were analyzed with generalized estimating equations. Results: Average follow-up was 4.3 years. There was no statistical difference between groups using complete remission American Diabetes Association criteria (OR 2.214, 95%CI 0.800-5.637, p=0.13). There was significant difference between groups using partial remission American Diabetes Association criteria (p=0.002), favouring the CG group (OR 6.392, 95%CI 1.922-21.260). The higher BMI group also had lower HbA1c levels (-0.77%, 95%CI -1.26 to -0.29, p=0.002). There were no significant differences in remission of hypertension, dyslipidemia and surgical morbidity, while weight was better controlled in the IG group. Conclusion: No differences were found in diabetes complete remission, although greater partial remission and the lower levels of glycated hemoglobin in the BMI >35 kg/m2 group suggest a better response among more obese diabetic patients with LRYGB. In addition, both groups had important metabolic modifications at the expense of low morbidity.

RESUMO Racional: Diabete mellito tipo 2 apresenta alta taxa de remissão em longo prazo após derivação gástrica em Y-de-Roux (DGYR), mas poucos estudos analisaram pacientes com IMC <35 kg/m2. Objetivo: Comparar o controle glicêmico de pacientes após DGYR entre IMC 30-35 kg/m2 (grupo intervenção ou GI) e >35 kg/m2 (grupo controle ou GC) e avaliar a perda de peso, comorbidades e morbidade cirúrgica. Método: Sessenta e seis pacientes diabéticos (30 no grupo GI e 36 no GC) foram submetidos à DGYR. Dados foram coletados anualmente após a operação e analisados com equações de estimativa generalizada. Resultados: A média de seguimento foi 4,3 anos. Não houve diferença estatística entre os grupos usando critérios de remissão completa da American Diabetes Association (OR 2,214, 95%IC 0,800-5,637, p=0,13). Houve diferença significativa entre os grupos usando critérios de remissão parcial da American Diabetes Association (p=0,002), favorecendo o grupo GC (OR 6,392, 95%IC 1,922-21,260). O grupo com IMC maior também teve menores níveis de HbA1c (-0,77%, 95%IC -1,26 a -0,29, p=0,002). Não houve diferença significativa na remissão de hipertensão, dislipidemia e morbidade cirúrgica, enquanto o peso foi melhor controlado no grupo GI. Conclusão: Nenhuma diferença foi encontrada na remissão completa do diabete, embora maior remissão parcial e menores níveis de hemoglobina glicada no grupo com IMC >35 kg/m2 sugiram melhor resposta entre diabéticos mais obesos com DGYR. Além disso, ambos os grupos tiveram importantes modificações metabólicas às custas da baixa morbidade.

Hepatic phosphoenolpyruvate carboxykinase expression after gastric bypass surgery in rats with type 2 diabetes mellitus / 中华内分泌外科杂志

Objective To investigate mRNA expression of hepatic phosphoenolpyruvate carboxykinase (PEPCK) after gastric bypass surgery (GBS) in rats with type 2 diabetes mellitus (T2DM).Methods 36 male Goto-Kakizaki rats,aged 12 weeks,were randomly divided into GBS,sham operation with diet restriction (SO),and sham operation alone(control) groups(n=12 per group).The blood lipid levels and fasting plasma glucose (FPG)levels in rats before and 8 weeks after surgery were measured and compared.The insulin sensitivity index (ISI)was calculated.Real-time polymerase chain reaction (RT-PCR) and Western blot were used to detect the expression of PEPCK mRNA and protein in hepatocytes at 8 weeks after operation.Results 8 weeks after operation,the blood lipid levels [TC(1.25±0.08) mmol/L,TG (0.93±0.10) mmol/L,FFA(0.88±0.12) mmoUL] in GBS group were significantly lower than those before operation [TC (2.31 ±0.52) mmol/L,TG(1.44±0.27) mmol/L,FFA (1.08±0.06) mmol/L] (P＜0.05).The fasting blood glucose levels in GBS decreased from (11.73±0.37) mmol/L to (5.13±0.22) mmol/L (P＜0.05),and ISI in GBS group increased from (-5.78±0.10) to (-4.64±0.15) (P＜0.05).PEPCKmR-NA (3.97±0.30) and protein (1.60±0.31) expression significantly reduced (P＜0.05).Conclusion GBS can reduce blood glucose in T2DM rats while improving glucose tolerance and hyperglycemia,and the mechanism appears to be associated with a decrease of hepatic PEPCK mRNA and protein expression.

Impact of Roux-en-Y gastric bypass surgery on the brown adipose tissue of type 2 diabetic rats / 中华内分泌外科杂志

Objective To observe what changes the brown adipose tissue (BAT) of T2DM rat models would have,including morphology,function and specially expressed uncoupling protein (UCP1) after the gastric bypass (Roux-en-Y,RYGB) and to explore the effects of RYGB on BAT of T2DM rat models and its related mechanism in order to provide a theoretical and experimental basis for treatment of T2DM patients with RYGB.Methods SD rats were given a high-fat and high-sugar diet for two weeks,by injecting streptozotocin (STZ) 30 mg/kg intraperitoneally to build models.Blood glucose was measured after 72 h and 1 week by the fast blood glucose meter.The models were built successfully if blood glucose at both times were ≥ 16.7 mmol/L.Feeding environment:individually caged,standard rat feed,natural circadian cycle,indoor temperature (18±2)℃,indoor humidity (50±2)％.50 rats were randomly selected and dividing into four groups according to intervention methods:diabetes operation group (group A,n=10),undergoing RYGB surgery with the whole stomach kept;diabetes sham operation group (group B,n=10),the same anesthesia and incision as the previous RYGB group.The operation mode was anterior gastric wall incision and suture,jejunum transection in corresponding position and in situ anastomosis with the same suture method as group A;diabetes control group (group C,n=10),normally feeding after building models;and the last one was the healthy control group (group D,n=10):no special treatment,adequate water feeding ensured.The rest of rats remained to be used.The body mass (BM),fasting blood glucose (FBG),fasting serum insulin(Fins)before and at the 1st,2nd,4th and 8th week after surgery were measured.The number of transversal ceils was calculated by IPP6.0 image software and the average radius of fat cells was calculated.UCP1 expression was tested with western blot.Results ① The fasting blood glucose,fasting serum insulin level and the body weight of dia betic rats were higher than those of the control group,but the insulin sensitivity index was significantly lower.② HE Staining showed:diabetes operation group (group A) rats,compared with diabetes control group and diabetes sham operation group(group B),had obviously higher brown fat cell counts transversally and average radius,and the difference was statistically significant (P＜0.01).Diabetes operation group (group A) rats had no significant difference from the healthy control group(group D) rats,and the diabetes control group (group C) rats had no significant difference from sham operation group (group B) rats as well.③ Western blot showed that after the gastric bypass surgery,compared with the diabetes sham operation group (group B) and the diabetes control group (group C),UCP1 expression of brown adipose tissue of the diabetes operation group (group A) increased significantly (P＜0.05).The diabetes sham operation group (group B) had no significant difference from the diabetes control group (group C),and the diabetes operation group(Group A) had no significant difference from the healthy control group (Group D) as well (P＞0.05).Conclusion RYGB can reduce the body mass and insulin resistance (IR) of diabetic rats and,at the same time,promote the expression of UCP1 of brown adipose tissue.RYGB might increase the activity of brown adipose tissue by regulating the UCP1 signaling pathway to improve body's insulin resistance.

Establishment of gastric bypass surgery model on rats and influence factors / 局解手术学杂志

Objective To establish gastric bypass surgery model with SD rat and analyze the influence factors and preventive measures so as to accumulate experience and skills for further developing gastric bypass surgery model on diabetic rat( GK rat) . Methods Gastric by-pass surgery was operated on 30 SD rats. Summarized modeling experience and analyzed various factors affecting modeling success. Results 17 rats weresuccessfully survived after surgery and 13 failed, with the mortality rate 43. 3%. Three rats died during operation, including two for anesthesia and one for heart failure;one died due to anastomotic bleeding two hours after surgery. Eight died in the third day after surgery, including two for infection, two for intestinal necrosis, four for anastomotic stenosis or obstruction. One died because of anastomotic leakage caused by mistaking and satiety the fifth day after surgery. There were no other complications such as wound dehiscence occurred in this group . Conclusion Establishing models of gastric bypass surgery with SD rats which is regarded as pre-experiment of building models of gas-tric bypass surgery with GK rats is economical and feasible. Anesthesia and perioperative management, surgical techniques and infection pre-vention and control are the main factors affecting modeling. The survival rate of rat model could be increased if related factors well controlled.

Comparison of the efficacies of laparoscopic Roux-en-Y gastric bypass surgery in the treatment of patients with different body mass indexes combined with type 2 diabetes mellitus / 中华消化外科杂志

Objective To investigate the efficacies of laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery in the treatment of patients with different body mass indexes (BMI) and type 2 diabetes mellitus.Methods The clinical data of 40 patients with type 2 diabetes mellitus who underwent LRYGB surgery at the Shengjing Hospital of China Medical University from January 2013 to December 2013 were retrospectively analyzed.According to different BMI,8 patients with BMI ＜ 27.5 kg/m2 were allocated into group 1,14 patients with BMI≥27.5 kg/m2 and ＜32.5 kg/m2 in group 2 and 18 patients with BMI≥32.5 kg/m2 in group 3.Forty patients were followed up via telephone interview and food habits questionnaire by weight loss file managers of Shengjing Hospital and the fourth Affiliated Hospital of China Medical University.All the patients received the reexamination of blood test and data collection at postoperative year 1.The preoperative and postoperative 1-year fasting plasma glucose,glycosylated hemoglobin (HbA1 c),BMI and C-peptide were collected and detected.The fasting plasma glucose ＜ 7.00 mmol/L and HbA1 c ＜ 7.00％ were used as a standard of complete remission.Count data and comparison of rates were analyzed using the chi-square test.Measurement data with normal distribution were presented as x ± s and analyzed by the t test.Skew distribution data were described as M (range) and analyzed by the Wilcoxon rank sum test.Repeated measurement data were analyzed by the repeated measures ANOVA.Results Forty patients received successful LRYGB surgery without perioperative complications,and were followed up for 1 year at the Shengjing Hospital (23 patients),the fourth Affiliated Hospital (8 patients) and other hospitals (9 patients).Of the 40 patients,85.0％ (34/40) of patients had no postoperative long-term obvious malnutrition,anastomotic stenosis,ion disorders and digestive tract dynamic obstacles,15.0％ (6/40) of patients were not adapted to the change of life habits such as frequent nausea and vomiting.Five patients with different degrees of frequent vomiting,abdominal pain and night heartburn within postoperative 1 month had the remission of synptoms after symptomatic treatment.One patient in group 2 had a symptom of hypertonic coma due to intake of oral high-sugar drinks at postoperative 1 week and then was cured by hospitalization.The fasting plasma glucose,HbA1c and BMI in group 1 from preoperation to postoperation were decreased from 11.07 mmol/L (range,6.00-17.00 mmol/L) to 7.18 mmol/L (range,6.00-15.00 mmol/L),from 8.85％ (range,6.00％-11.00％) to 6.35％ (range,6.00％-9.00％) and from 26.0 kg/m2 (range,22.0-27.0 kg/m2) to 22.2 kg/m2 (range,20.0-25.0 kg/m2),with significant differences (F =2.413,3.256,6.750,P ＜ 0.05).C-peptide from preoperation to postoperation was decreased from 1.20 nmol/L (range,1.00-3.00 nmol/L) to 1.07 nmol/L (range,1.00-2.00 nmol/L),with no significant difference (F =1.678,P ＞ 0.05).The remission rate of diabetes in group 1 was 3/8.The fasting plasma glucose and HbA1c in group 2 from preoperation to postoperation were decreased respectively from 10.73 mmol/L (range,7.00-19.00 mmol/L) to 5.89 mmol/L (range,5.00-9.00 mmol/L) and from 8.00％ (range,6.00％-15.00％) to 5.85％ (range,5.00％-8.00％).The BMI from preoperation to postoperation was decreased from 31.0 kg/m2 (range,29.0-32.0 kg/m2) to 25.5 kg/m2 (range,21.0-29.0 kg/m2),with significant differences in the above 3 indexes (F =5.449,4.008,-3.296,P ＜ 0.05).C-peptide from preoperation to postoperation was decreased from 1.53 nmol/L (range,1.00-5.00 nmol/L) to 1.52 nmol/L (range,1.00-6.00 nmol/L),with no significant difference (F =-0.251,P ＞ 0.05).The remission rate of diabetes in group 2 was 10/14.The fasting plasma glucose,HbA1c and BMI in group 3 from preoperation to postoperation were decreased from 9.44 mmol/L (range,5.00-16.00 mmol/L) to 6.65 mmol/L (range,4.00-15.00 mmol/L),from 7.90％ (range,6.00％-11.00％) to 6.45％ (range,5.00％-9.00％) and from 36.9 kg/m2 (range,33.0-47.0 kg/m2) to 27.7 kg/m2 (range,23.0-34.0 kg/m2),with significant differences (F =-3.027,-3.410,-3.724,P ＜ 0.05).C-peptide from preoperation to postoperation was decreased from 2.91 nmol/L (range,0.00-9.00 nmol/L) to 2.13 nmol/L (range,0.00-6.00 nmol/L),with no significant difference (F =-3.724,P ＞ 0.05).The remission rate of diabetes in group 3 was 14/18.There was no significant difference in the remission rate of diabetes of 3 groups (x2 =4.460,P ＞ 0.05).There were significant differences in the changing trends of fasting plasma glucose and BMI among the 3 groups (F =3.200,22.500,P ＜ 0.05).There were no significant differences in the changing trends of HbA1c and C-peptide among the 3 groups (F =0.720,1.640,P ＞ 0.05).Conclusion LRYGB surgery is feasible for the treatment of type 2 diabetes mellitus with effectively decreasing fasting glucose,and should be performed on patients with BMI ≥ 27.5 kg/m2 instead of patients with BMI ＜ 27.5 kg/m2 according to a correlation of blood glucose control and preoperative BMI.

Surgical Treatment of Obesity and Diabetes.

Surgery for obesity is the last option but it is the most effective. Resolution of comorbid diseases with obesity occurs depending upon the amount of weight loss, age of the patients, duration of comorbid disorders. After malabsorptive surgeries, patient has to be on life-long vitamin supplements. Various types of surgeries done in morbid obesity with their merits and demerits have been described in this review.

Effect of gastric bypass surgery on fasting blood glucose and pancreatic islet cell in type 2 diabetic rats / 中华内分泌外科杂志

Objective To study the effect and mechanism of gastric bypass surgery on type 2 diabetic rats.Methods The models of type 2 diabetic rats were induced by stretozotocin and 20 diabetic rats were randomly divided into 2 groups:diabetes-operation group (DO group,n =10)and diabetes-control group(DC group,n =10).20 normal rats were randomly divided into 2 groups:normal-operation(NO group,n =10) and normalcontrol group(NC group,n =10).Rats in DO and NO group underwent GBP and rats in DC group and NC group underwent sham operation.Fasting blood glucose(FBG) levels of rats in each group were detected before operation and on 72 h,1th week,4th week,8th week after operation.On the 8th week after operation,pancreas tissues were harvested for HE staining and immunofluorescence,histological changes observed.Results The FBG levels of rats were not statistically significant different before operation between DO group and DC group or between NO group and NC group (P ＞ 0.05).After operation,the FBG levels of rats in DO group gradually declined (P ＜ 0.05).FBG levels of rats in DO group were lower after operation than before operation(P ＜0.05) ; After operation FBG levels of rats were higher in DO group than in NO group and NC group at the same time point (P ＜0.05).In DC group,the difference of FBG levels of rats at different time point was not statistically significant(P ＞ 0.05).The difference of FBG had no statistically significance between the different time points of the same group or between the same time point of different groups (P ＞ 0.05).HE staining showed that,in DO group,newborn small islets appeared in pancreas which increased the number of islet.The new islets were smaller,mostly around the pancreatic duct and the structure was similar to that of the normal islets.Immunofluorescence staining also showed that the number of islets increased.Insulin immunofluorescence found more isolated small islets composed of two or three insulin positive cells.Insulin and glucagon double immunofluorescence found insulin and glucagon double positive(INS +/GLU +)cells in some islets.Conclusions GBP has obvious hypoglycemic effects on FBG levels of type 2 diabetic rats,in which the regeneration of pancreas islets may play an important role,while on normal rats GBP has no hypoglycemic effects.

Analysis of clinical effect and management status of 57 patients with type 2 diabetes mellitus after gastric bypass operation / 中国医师进修杂志

Objective To investigate the clinical effect of gastric bypass operation on treating type 2diabetes,and analyze the management status.Methods Fifty-seven patients wiith type 2 diabetes treated by gastric bypass operation were divided by different body mass index(BMI) into 4 groups:group A( BMI ＜ 20kg/m2) with 8 cases,group B (20 kg/m2≤BMI ＜24 kg/m2) with 21 cases,group C (24 kg/m2≤BMI ＜27kg/m2) with 17 cases and group D (BMI ≥27 kg/m2) with 11 cases.The control of blood glucose and glycosylated hemoglobin,changes of diets and body weight,diabetes complications,adverse reactions after operation and postoperative management were followed up or reviewed.The clinical data were analyzed comprehensively.Results The cure rate of group C was the highest [ 70.6％( 12/17 ) ],while the cure rate of group A was the lowest (0).The overall cure rate was 43.9％(25/57) and the overall improvement rate was 28.1％(16/57).The overall efficient rate was 71.9％(41/57) and the overall inefficient rate was 28.1％(16/57).Apart from a few patients had malnutrition,amenorrhea,bad stomach,diarrhea and poor diet after leaving the hospital,other patients had no surgery complications and no patients died.There was no clinician to follow up and did education to these patients after operation.Conchusions Gastric bypass operation is safe and effective for obese and non-obese patients with type 2 diabetes.It is a new method to weat type 2diabetes at present,but the indications should be grasped and operation enlargement must he prevented.The management of teams of physicians,surgeons,dietitians,nurses should be established afler operation.

Short term effect of gastric bypass surgery for the treatment of nonobese type 2 diabetes mellitus / 中华消化外科杂志

Objective To investigate the short term effect of gastric bypass surgery for the treatment of nonobese type 2 diabetes mellitus and possible mechanisms. Methods The clinical data of 58 patients with nonobese type 2 diabetes mellitus who received gastric bypass surgery from March to August, 2009 were retrospectively analyzed. The levels of fasting plasms glucose (FPG), 2-hour postprandial plasma glucose (2h PG) and glycosylated hemoglobin (HbA1c) were dynamically monitored, and the insulin resistance index (HOMA-IR) and body mass index ( BMI) were calculated. All data were analyzed using variance of analysis and LSD test. Results Of the 58 patients, 48 (83% ) met the requirement of complete response criteria and stopped administration of hypoglycemic agents; 7( 12% ) had to use hypoglycemic agents, but the dose of the agents was lowered by 50% compared to that before surgery. The surgery was ineffective in 3 patients (5% ). The levels of FPG, 2h PG, HbAlc and HOMA-IR of the 58 patients showed a significant decreasing trend after surgery when compared to those before surgery (F = 67. 867, 50. 885, 78. 278, 572. 757, P 0. 05 ). Conclusions Gastric bypass surgery has a good effect on nonobese patients with type 2 diabetes mellitus whose BMI was less than 25 kg/m2. The improvement of insulin resistance after the surgery might be the main reason.

Mechanism of gastric bypass surgery in the treatment of type 2 diabetes mellitus in a rat model / 中华消化外科杂志

Objective To investigate the mechanism of gastric bypass surgery in the treatment of type 2 diabetes mellitus in a rat model. Methods Seventy-two 8-week-old GK rats were randomly divided into operation group, sham operation group, diet control group and control group (18 rats in each group) according to the random number table. Rats in the operation group and the sham operation group received gastric bypass surgery and transection and reanastomosis of the gastrointestinal tract, respectively. The food intake was set as 15 g/d for each rat in the diet control group, while rats in the control group were fed ad libitum. The levels of fasting blood glucose ( FBG), postprandial blood glucose (PPBG) and glucagon-like peptide-1 (GLP-1) were detected before operation and at postoperative week 2, 4 and 8. The levels of PPBG and GLP-1 were detected at postoperative week 2, 4 and 8, then 6 rats of each group were sacrificed to detect the apoptosis of islet B cells using the TUNEL method. All data were analyzed using the t test. Results In the operation group, the preoperative levels of FBG and PPBG were (16.2±0.8)mmol/L and (31.1 ± 1. L)mmol/L, respectively, which were significantly higher than (9.2± 0.6) mmol/L and (13.1 ±0.7) mmol/L at 4 weeks after the operation, and (9. 7 ± 0. 7) mmol/L and (12. 3 ± 0.7) mmol/L at 8 weeks after the operation (t = 20. 7, 49. 7; 18. 8, 39. 0, P < 0.05 ). The levels of FBG and PPBG before the operation and at 4 and 8 weeks after the operation in the operation group were significantly lower than those in the sham operation group, diet control group and control group at corresponding time points (t = 27.7, -57.8; 11.3, -59.9; -27.4, -48.2; -13.2, -52.7; -7.0, -24.9; -18.2, -56.4, P<0.05). In the operation group, the levels of fasting GLP-1 and postprandial GLP-1 were ( 10. 7 ± 1. 0) pmol/L and (42.5 ±1.2)pmol/L, respectively, which were significantly lower than (26. 1 ±0.9)pmol/L and (90.7 ± 1.7)pmol/L at4 weeks after the operation, and (25.3 ± 1.2)pmol/L and (90.4 ±2.0)pmol/L at 8 weeks after the operation (t=42.1, -92.4; -29.1, -72.7, P <0.05). The levels of fasting GLP-1 and postprandial GLP-1 before the operation and at 4 and 8 weeks after the peration in the operation group were significantly higher than those in the sham operation group, diet control group and control group at corresponding time points (t = 48.0, 61.9; 38.0, 62.2; 50.9, 65.2; 37.0, 48. 1; 27.5, 51.6; 17.5, 52.9, P<0.05). The number of the apoptotic islet β cells in the operation group was decreased with time. The apoptosis rates in the operation group, sham operation group, diet control group and control group were 5.9%±0.7% , 47.2%± 1.0% , 21. 1%± 1. 2% , 46.5%±1.4% at 4 weeks after the operation, and 6.3%±1. 1% , 47.2%±1.0% , 21.2%±1.2% and 46.0% ± 1.4% at 8 weeks after the operation. The apoptosis rates in the operation group were significantly lower than those in the sham operation group, diet control group and control group at corresponding time points (t = -82. 2, - 67. 0; - 27. 1, - 22. 4; - 55. 2, - 54. 6, P < 0.05). Conclusion After gastric bypass surgery, the level of blood glucose reduces and the level of GLP-1 increases which significantly inhibit the apoptosis of islet B cells in rats with type 2 diabetes mellitus.

Prospective controlled clinical study on gastric bypass surgery for nonobese type 2 diabetes mellitus / 中华消化外科杂志

Objective To investigate the efficacy of gastric bypass surgery for the treatment of nonobese type 2 diabetes mellitus. Methods From November 2008 to August 2009, 40 patients with gastric diseases and nonobese type 2 diabetes mellitus were admitted to the Changhai Hospital, and their clinical data were prospectively studied. All patients were randomly divided into 4 groups; 10 patients received Billroth I distal gastrectomy +gastroduodenal anastomosis (BⅠ group) , 10 received proximal gastrectomy + remanant gastric esophageal anastomosis ( PG group), 10 received total gastrectomy + esophagoduodenal Y-anastomosis ( RY group) and 10received subtotal gastrectomy Billroth Ⅱ gastro-jejunostomy (BⅡ group). The length of hospital stay, pre- and postoperative body mass indexes (BMIs) , waist circumferences, levels of fasting blood glucose (FBG) , glycated hemoglobin ( GHbA1) , fasting serum insulin (FSI) and fasting C-peptide (FCP) of patients in the 4 groups were compared. All data were analyzed using analysis of variance, LSD-t test, paired t test or chi-square test. Results The clinical effects of the 4 different operative procedures on the gastric diseases were similar. The levels of FBG were (8.0 ±2.9)mmol/L before operation and (5.9 ±0.7)mmol/L after operation in the RY group, with a significant difference (t = 2. 342, P < 0. 05). The preoperative level of GHbA1 in the RY group was 7.7% ± 1.1%, which was significantly higher than 6. 9% ± 0. 6% at 2 months after the operation and 6. 1 % ± 0. 4% at 6 months after the operation (t = 4. 920, 3.012, P < 0.05). The preoperative level of FCP in the RY group was (1.30 ±0.54) μg/L, which was significantly lower than (1.95 ± 0.86) μg/L at 2 months after the operation and (2.18 ± 0.63)μg/L at 6 months after the operation (t =6. 063, 4. 651, P < 0.05). The levels of FSI in the RY group at postoperative month 1, 2 and 6 were (18 ±5) , (19 ±3) , (21 ±3) mU/L, which were significantly higher than the level of FSI [(11 ±4) mU/L]before operation (t =3. 158, 4. 502, 7. 517, P <0. 05). Preoperative levels of FBG, GHbA1, FSI and FCP in the B Ⅱ group were (8. 3 ± 1. 3) mmol/L, 7. 7% ±0. 9% , (13±4)mU/L and (1.34±0.48) μg/L, which were ignificantly different from (6.7 ± 1.2)mmol/L, 6.8%± 0.8%, (18±4)mU/L and ( 1.68 ±0.46) μg/L at postoperative month 1, (6.4 ± 1.3)mmol/L, 6.3% ±0.6% ,(18±4)mU/L and (1. 96 ± 0. 67) μg/L at postoperative month 2, and (5. 6 ±0. 7) mmol/L, 6.0%±0.3%, (19 ± 4) mU/L and (2.27 ± 0. 59) |μg/L at postoperative month 6 (t = 2. 468, 2. 598, 6. 028; 3. 055, 4. 586,4.572; 3.618, 5.860, 8.577; 2.300, 3.511, 3.943, P<0.05). The levels of FBG,GHbA1 and FCP in the 4 groups at 2 months after surgery were significantly different from those at 6 months after surgery (F = 4. 699,14. 378; 7.411, 29. 192; 3. 335, 9. 334, P < 0.05). The levels of FSI in the 4 groups at different time points were significantly different (F =2. 896, 7. 012, 11. 998, P < 0.05). Conclusion The efficacy of gastric bypass surgery for the treatment of nonobese type 2 diabetes mellitus is satisfactory.

Repercussão da perda de peso sobre parâmetros nutricionais e metabólicos de pacientes obesos graves após um ano de gastroplastia em Y-de-Roux / Nutritional and metabolic evaluation of patients after one year of gastric bypass surgery

OBJETIVO: Avaliar a evolução metabólico-nutricional e a atividade inflamatória em pacientes com obesidade grave submetidos à cirurgia bariátrica. MÉTODOS: Realizou-se um estudo prospectivo em 56 pacientes (50 mulheres e seis homens), apresentando média de idade de 40 +/- 9,9 anos, submetidos à RYGB. Avaliação metabólica e nutricional e da atividade inflamatória foram verificadas antes, seis e 12 meses após o procedimento cirúrgico. RESULTADOS: Verificou-se redução significativa nos valores iniciais, em relação à perda de peso de 138 ± 28,8 to 90 ± 19,5 kg (p< 0,0001), glicemia de 116 ± 47,3 to 84 ± 9,8 mg/dL (p< 0,0001), níveis de triacilglicerol de 137 ± 61,4 to 84 ± 38,6 mg/dL (p< 0,0001), colesterol total de 189 ± 41,6 to 166 ± 36,4 mg/dL (p< 0,0001) e LDL-colesterol de 119 ± 36,1 para 104 ± 30,7 mg/dL (p< 0,0005). Os níveis de proteína C-reativa reduziram de 11,33 ± 10,82 para 3,62 ± 4,49 mg/dL (p< 0,0001). Embora os níveis de ferro tenham permanecido dentro do limite de normalidade, após um ano, observou-se diminuição significativa na hemoglobina de 13 ± 1,3 para 12 ± 1,4 g/dL (p< 0,01), e redução nos níveis de ferritina, particularmente nas mulheres, que apresentou queda de 101,2 ± 123,3 para 85,0 ± 101,9 g/dL (p< 0,03). CONCLUSÃO: A melhora verificada no estado metabólico e inflamatório concomitantemente após tratamento cirúrgico pode reduzir substancialmente as co-morbidades associadas com o risco cardiovascular aumentado.

OBJECTIVE: To assess nutritional and metabolic evolution and inflammatory activity in severe obese patients submitted to bariatric surgery. METHODS: This prospective study evaluated 56 patients (50 female and 6 male), mean age 40 ± 9,9 years, submitted to RYGB. Nutritional, metabolic, and inflammatory parameters were assessed prior to and 12 months postsurgery. RESULTS: It was verified significant decreases in weight loss in relation to baseline values from 138 ± 28,8 to 90 ± 19,5 kg (p< 0,0001), glucose levels from 116 ± 47,3 to 84 ± 9,8 mg/dL (p< 0,0001), triacylglycerol levels from 137 ± 61,4 to 84 ± 38,6 mg/dL (p< 0,0001), and also in total cholesterol from 189 ± 41,6 to 166 ± 36,4 mg/dL (p< 0,0001) and LDL-cholesterol from 119 ± 36,1 to 104 ± 30,7 mg/dL (p< 0,0005). C-reactive protein levels reduced from 11,33 ± 10,82 to 3,62 ± 4,49 mg/dL (p< 0,0001). Although maintenance of iron levels was verified after one year, there was a significant decrease in hemoglobin from 13 ± 1,3 to 12 ± 1,4 g/dL (p< 0,01), and reduction in ferritin levels, especially in women who showed a decrease from 101,2 ± 123,3 to 85,0 ± 101,9 (p< 0,03). CONCLUSION: Therefore, weigh loss in patients with severe obese after RYGB showed improvement in both metabolic and inflammatory status and may reduce substantially co-morbidities associated with increased cardiovascular risk.

Cirugía Bariátrica en el Hospital de San José, Bogotá D. C.: experiencia y resultados / Bariatric surgery at Hospital de San José Bogotá DC: expertise an results

En los últimos años se ha dado gran importancia al tratamiento de la obesidad por el incremento de la incidencia a nivel mundial y a la falla del tratamiento médico en algunos tipos. Por eso hoy se practican con mayor frecuencia procedimientos de tipo bariátrico. Objetivo: describir la experiencia y resultados en el Hospital de San José de Bogotá D.C. entre enero 2006 y abril 2009. Métodos: cohorte de 146 pacientes con indicación de cirugía bariátrica en el período mencionado. Resultados: 54 hombres (37%) con edad promedio de 54 años (DE: 10,5) y 92 mujeres (37%) con 43 años (DE: 11). El promedio de índice de masa corporal de cirugía fue 43 k/m2 (DE: 5.1); veinte (13,7%) se catalogaron superobesos. Las comorbilidades fueron hipertensión arterial (43,1%), hipercolesterolemia (40,4%) y diabetes mellitus (34,9%). Hubo antecedente de cirugía abdominal en 34,2%. Todos los procedimientos corresponden a by pass gástrico, excepto uno de manga gástrica. El promedio de pérdida de peso entre el octavo y décimo mes fue 55% (DE: 9:9.1), con reducción de glicemia en ayunas y del perfil lipídico. No se obtuvieron datos en la totalidad de la población. La complicación más frecuente fue la ISO presente en doce (8,2%), de los cuales ocho (5,5%) tuvieron infección de cavidad. La fuga anastomótica se documentó en siete (4,8%), hernia interna en tres (2,1%), estenosis anastomótica y peritonitis secundaria en dos (1,4%). No se reportaron hemoperitoneo, úlcera marginal ni hernia incisional. El tiempo quirúrgico promedio fue 106 minutos (DE: 22) y en 25 (17,1%) se prolongó (mayor o igual a 120 minutos). El tiempo mediano de estancia hospitalaria fue cuatro días. La mortalidad global intrahospitalaria fue de siete (4,7%), distribuida así: ningún caso en 2006 (35 cirugías), cuatro en 2007 (59 cirugías, 6,7%), uno en 2008 (29 cirugías, 3,4%) y dos en 2009 (22 cirugías, 9%). Conclusiones: los pacientes llevados a cirugía bariátrica en el Hospital de San José...

Treatment for obesity has gained importance over the last few years as a result of increased global incidence and lack of medical therapeutic options for some types of overweight. Thus bariatric procedures are more frequently practiced nowadays. Objective: to describe expertise and results at Hospital de San José, Bogotá DC between January 2006 and April 2009. Methods: cohort of 146 patients with an indication for bariatric surgery during named period. Results: 54 males (37%), mean age 54 years (SD: 10.5) and 92 females (37%), mean age 43 years (SD: 11). The mean body mass index of candidates to bariatric surgery was 43 k/m2 (SD: 5.1); 20 (13.7%) were classified as extremely obese. Comorbid conditions included arterial hypertension (43.1%), hyperlipidemia (40.4%) and diabetes mellitus (34.9%). There was an abdominal surgery history in 34.2%. All the procedures corresponded to a gastric bypass surgery except for one sleeve gastrectomy. Mean weight loss between an 8-month and 10.month post-surgical follow-up period was 55% (SD: 9:9.1) with reduction of serum fasting glucose and lipid profile. Data from the total study population were not obtained. The most common complication was surgical site infection in 12 patients (8.2%), of which 8 (5.5%) had infection of the abdominal cavity. Anastomotic complications such as intestinal leaks was documented in 7 cases (4.8%), internal hernia in 3 (2.1%), strictures with peritonitis in 2 (1.4%). No cases of hemoperitoneum, marginal ulcers or incisional hernias were reported. Mean operating time was 106 minutes (SD: 22) and was greater in 25 (17.1%) cases (= 120 minutes). Mean hospital stay was four days. The overall mortality rate in hospitalized patients was 7 (4.7%), as follows: zero in 2006 (35 surgeries), 4 in 2007 (59 surgeries, 6.7%), 1 in 2008 (29 surgeries, 3.4%) and 2 in 2009 (22 surgeries, 9%). Conclusions: Those who underwent bariatric surgery at Hospital de San José...

Laparoscopic Roux-en-Y gastric bypass for morbid obesity:Follow-up results in 121 patients / 中国微创外科杂志

Objective To summarize the changes of nutrition and metabolism after laparoscopic Roux-en-Y gastric bypass surgery (LRYGBP) in the treatment of morbid obesity. Methods LRYGBP was performed in 121 patients with morbid obesity (male, 40 patients; femal, 81 patients). The body mass index (BMI) was measured 1 month before and 6 months after the operation. A comparative analysis was conducted on serum levels of ferrum (Fe), calcium (Ca), zincum (Zn), selenium (Se), vitamin A (VitA), vitamin D (VitD), vitamin B_ 12 (VitB_ 12 ), and parathyroid hormone (PTH) at 6, 12, and 24 months after operation. Results The BMI was declined from 47.00?7.15 kg/m~2 preoperatively to 33.79?6.06 kg/m~2 postoperatively, with a decrease of 0.26~42.58 kg/m~2 (13.21?5.47 kg/m~2) (t=26.103, P=0.001). The postoperative serum levels of Fe, Ca, Zn, Se, VitA, VitD, and VitB_ 12 were all within the normal limits. However, the levels of Zn, Se, and VitA were lower than the normal in 19.5% (17/87), 22.7% (20/88), and 3.7% (28/83) of patients at 6 months after operation, and in 6.0% (2/30), 11.5% (3/26), and 17.2% (5/29) of patients at 2 years after operation, respectively. The serum PTH levels were 11~161 pg/ml (66?34 pg/ml), 24~154 pg/ml (72?34 pg/ml), and 21~194 pg/ml (75?40 pg/ml) at 6, 12, and 24 months after operation, respectively (normal limits, 9~44 pg/ml). Conclusions Laparoscopic Roux-en-Y gastric bypass surgery is a reliable and safe option for patients with morbid obesity. The serum levels of calcium, zinc, selenium, and PTH will be influenced following the surgery. Supplementation of multi-vitamins and mineral substances should be strongly advised in all patients.